Thursday, May 30, 2024
12:00PM – 1:30PM ET
Please note this rebroadcast is at 12:00PM Eastern, 11:00AM Central, 10:00AM Mountain and 9:00AM Pacific.
FACULTY
 |
JoAnn V. Pinkerton, MD, MSCP, FACOG Professor of Obstetrics and Gynecology Division Director, Midlife Health The University of Virginia Health System Charlottesville, VA |
 |
James A. Simon, MD, CCD, MSCP, IF, FACOG Clinical Professor George Washington University IntimMedicine Specialists Washington, DC |
LEARNING OBJECTIVES
- Assess the pathophysiological mechanisms that result in Vasomotor Symptoms (VMS) due to menopause
- Evaluate traditional treatment options for patients with VMS due to menopause
- Develop strategies that allow for effective communication with patients on issues and challenges associated with VMS due to menopause
TARGET AUDIENCE
This activity is designed to meet the educational needs of US-based obstetrician-gynecologists, primary care physicians including internists, family practitioners, nurse practitioners, physician assistants, nurses, and additional healthcare providers who treat menopausal women.
JOINT ACCREDITATION STATEMENT
In support of improving patient care, Med Learning Group is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
PHYSICIAN CREDIT DESIGNATION STATEMENT
Med Learning Group designates this live activity for a maximum of 1.5 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the live activity.
NURSES (ANCC) CREDIT DESIGNATION
Med Learning Group designates this activity for a maximum of 1.5 ANCC contact hours.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CE activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.
During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.
DISCLAIMER
Med Learning Group makes every effort to develop CE activities that are science based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making expertise before applying any information, whether provided here or by others, for any professional use.
For CE questions, please contact Med Learning Group at [email protected]
Contact this CE provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITIES ACT
Event Staff will be glad to assist you with any special needs (eg, physical, dietary, etc). Please contact Med Learning Group prior to the live event at [email protected]
